News

For media inquiries, please contact:
Stephanie Dunn, Manager, Research Communications
sdunn@bcchr.ca | 604-875-2401

To subscribe to the media mailing list, please email comm@bcchr.ca with your name and affiliation.

Click on a tag to sort the news stories by theme:


Two commonly used medications linked to serious eye conditions: studies

April 04, 2012
Share this:

A study published in the Canadian Medical Association Journal (CMAJ) showed that patients taking an osteoporosis drug called bisphosphonate have a higher risk of developing the inflammatory eye conditions uveitis and scleritis. A second study, published in the Journal of the American Medical Association (JAMA), showed that taking an oral antibiotic called fluoroquinolone is associated with a small but increased risk of retinal detachment. CFRI investigator Dr. Mahyar Etminan led both studies. He is affiliated with the University of British Columbia and Vancouver Coastal Health Research Institute.

[CMAJ news release] 

[Reuters Health story]  [Globe and Mail story]  [Edmonton Sun story]

[Canadian Press/Global News story]   [Insider Medicine video]

[JAMA study]  [CMAJ study]